
BlackRock Health Sciences Opportunities Portfolio Investor A Shares
SHSAX
Updated: 05/11/2026, 07:07:00
No historical data available
The fund primarily aims to generate significant capital appreciation for investors over an extended timeframe. To achieve this, it commits at least 80% of its overall assets to equity instruments, predominantly common stocks, of companies engaged in the health sciences and related fields. This specialized sector encompasses a broad spectrum of businesses, such as those involved in medical equipment and supplies, healthcare service delivery, advanced biotechnology, and pharmaceutical manufacturing. The portfolio maintains a concentrated investment approach, allocating more than 25% of its holdings to these health sciences and associated industries, and it also retains the flexibility to invest in companies based outside the United States.
No summaries found.
- Share price
- $70.20
- Market cap
- $6.44B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 20/12/1999
- Beta
- 0.484
- Last dividend
- $0.00
- Day range
- $68.26 – $70.20
- 52-week range
- $60.07 – $70.20
- 1-day performance
- 2.84%
- 1-year performance
- 16.86%
- Current drawdown (1Y)
- 0.00%
- CIK
- 0000844779
- CUSIP
- 091937573
- ISIN
- US0919375735
- Created
- 07/12/2025, 14:13:25
- Last update
- 05/11/2026, 07:07:00
Track BlackRock Health Sciences Opportunities Portfolio Investor A Shares with an AI analyst
See which prediction-market events move SHSAX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.